Cancer-related pain management update in 2025: refining established therapies and expanding toward integrated multimodal and longitudinal management.

Li Y, Cang J, Fang F

Open source

DOI
10.21037/tcr-2026-2152
Published
2026 Oct 30
Container
Translational cancer research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tcr-2026-2152,
  title = {Cancer-related pain management update in 2025: refining established therapies and expanding toward integrated multimodal and longitudinal management.},
  author = {Li Y and Cang J and Fang F},
  year = {2026},
  journal = {Translational cancer research},
  doi = {10.21037/tcr-2026-2152},
  url = {https://doi.org/10.21037/tcr-2026-2152}
}

RIS

TY  - JOUR
TI  - Cancer-related pain management update in 2025: refining established therapies and expanding toward integrated multimodal and longitudinal management.
AU  - Li Y
AU  - Cang J
AU  - Fang F
PY  - 2026
JO  - Translational cancer research
DO  - 10.21037/tcr-2026-2152
UR  - https://doi.org/10.21037/tcr-2026-2152
ER  - 

APA

Y, L., J, C., & F, F. (2026). Cancer-related pain management update in 2025: refining established therapies and expanding toward integrated multimodal and longitudinal management.. Translational cancer research. https://doi.org/10.21037/tcr-2026-2152

Source records